Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis.
Britanova OV, Lupyr KR, Staroverov DB, Shagina IA, Aleksandrov AA, Ustyugov YY, Somov DV, Klimenko A, Shostak NA, Zvyagin IV, Stepanov AV, Merzlyak EM, Davydov AN, Izraelson M, Egorov ES, Bogdanova EA, Vladimirova AK, Iakovlev PA, Fedorenko DA, Ivanov RA, Skvortsova VI, Lukyanov S, Chudakov DM.
Nat Med. 2023 Nov;29(11):2731-2736. doi: 10.1038/s41591-023-02613-z. Epub 2023 Oct 23.
PMID:37872223
Spondyloarthritides.
Baraliakos X, Braun J.
Best Pract Res Clin Rheumatol. 2011 Dec;25(6):825-42. doi: 10.1016/j.berh.2011.11.006.
PMID:22265264
Seronegative spondyloarthritides.
Calin A.
Med Clin North Am. 1986 Mar;70(2):323-36.
PMID:3485229
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.
Coates LC, Gossec L, Zimmermann M, Shawi M, Rampakakis E, Shiff NJ, Kollmeier AP, Xu XL, Nash P, Mease PJ, Helliwell PS.
RMD Open. 2024 Mar 26;10(1):e003977. doi: 10.1136/rmdopen-2023-003977.
PMID:38531621
Immunoglobulin G4-related spinal pachymeningitis.
Alrashdi MN.
Saudi Med J. 2020 Jun;41(6):652-656. doi: 10.15537/smj.2020.6.25086.
PMID:32518934
Psoriatic arthritis: A permanent new challenge for dermatologists (Review).
Dinu A, Bucur S, Olteanu R, Constantin T, Raducan A, Baetu M, Constantin MM.